Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.

Saved in:
Bibliographic Details
Title: Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.
Authors: Green BL; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Gamble LA; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Diggs LP; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Nousome D; Biomedical Informatics and Data Science, Frederick National Laboratory for Cancer Research, NCI, NIH, Frederick, Maryland., Patterson JC; Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, Maryland., Joughin BA; Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, Maryland., Gasmi B; Surgery Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lux SC; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Samaranayake SG; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Miettinen M; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland., Quezado M; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland., Hernandez JM; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Yaffe MB; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.; Koch Institute for Integrative Cancer Research, MIT Center for Precision Cancer Medicine, Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, Maryland., Davis JL; Surgical Oncology Program, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2023 Dec 01; Vol. 21 (12), pp. 1356-1365.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3125
DOI:10.1158/1541-7786.MCR-23-0122